Can Viagra Be Used To Treat Sexual Dysfunction In Women Taking Antidepressants?

Viagra is an erectile dysfunction medication and is prescribed for men who report problems of erectile dysfunction or impotency issues. However, a recent report suggests that Viagra can also be given for women having sexual dysfunction and if they are taking antidepressants. The side effect that happens in women who are suffering from a sexual dysfunction is due to using antidepressants. In this blog, you can get to know the role of Viagra in being able to treat sexual dysfunction in women who take antidepressants.

Role of Viagra

Selective serotonin reuptake inhibitors shortly termed as SSRI’s are a group of antidepressants which avert the reabsorption of neurotransmitter serotonin into neurons, thereby ameliorating the extracellular concentration of the chemical. They represent the most prescribed medications for outpatients who range in the age bracket of 18 to 65 years. These also constitute to about 90% of the 180 million antidepressant prescriptions in the US.

Research on Viagra for treating sexual dysfunction in women taking antidepressants

Researchers have discovered a commonly occurring side effect from the SSRI treatment and that is sexual dysfunction. Sexual dysfunctions that are due to the consumption of antidepressants are estimated to take place in about 30 to 70% of men and women who are being treated for major depression. First or second hand generation agents are the major reasons for the increased risk of no adherence that reaches 70% during the first month of treatment which in turn leads to higher relapse, disability, recurrence and also resource utilization by various patients. Prior to this, no randomized controlled trials have shown to bring treatment methods which are effective for sexual dysfunction in women due to the use of SSRI.

Comparison of Viagra and placebo

A few scientists compared sildenafil with that of placebo for treatment sexual dysfunctions http://buzzpharmacy.net/ that are related to SSRI’s, like lack of arousal or a delayed orgasm. In the study thus conducted, about 73% of women taking placebo showed no improvement upon receiving treatment when compared to the 25% of women who took sildenafil. When evaluated for clinical severity, women who were in the test group showed significant improvement for sexual functioning than those who were in the placebo group. No patient was withdrawn from the study on account of any serious or adverse effect though flushing, headache and indigestion were being reported from time to time.

Outcome

These researchers believe that this is an important discovery concerning the general health of women. These findings matter not only because women report major depressive disorder twice than what is experienced by men, but also because it can establish that selective phosphodiesterase type 5 inhibitors like sildenafil is highly effective for this purpose regardless of the orientation of sex.